Ongeno

Krakow, Poland · Founded 2017 · Privately Held (backing)

Operator of a medical technology intended to treat several autoimmune diseases. Ongeno is based in Krakow, Poland and was founded in 2017. Its last reported valuation was $72.6 million in Jan 2025. It has raised $3.6 million.

Last reported valuation
$72.6M
Oct 2026
Priced at
—
Total raised
$3.6M
Last round
—

Who backs Ongeno?

1 investors
InvestorType
JRHVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Ongeno investors

1 investor is on record for Ongeno, including JRH. By type, the record holds 1 venture capital firm.

Free account
More of Ongeno with a free account
  • ·Watch Ongeno: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 1 firms already write checks for companies like Ongeno. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View